We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current TNXP market cap is 86.37M. The company's latest EPS is USD -20.8674 and P/E is -0.72.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.99M | 3.78M | 2.48M | 2.21M | 2.82M |
| Operating Income | -28.15M | -27.33M | -21.35M | -77.32M | -15.55M |
| Net Income | -27.98M | -27.32M | -14.94M | -78.78M | -14.21M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 7.77M |
| Operating Income | -28.83M | -50.51M | -92.31M | -112.09M | -118.38M |
| Net Income | -31.09M | -52.17M | -92.29M | -116.88M | -116.66M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 139.28M | 154.46M | 135.34M | 70.31M | 94.99M |
| Total Liabilities | 18.45M | 48.93M | 27.2M | 28.2M | 20.78M |
| Total Equity | 120.83M | 105.53M | 108.14M | 42.1M | 74.21M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.56M | 98.18M | 240.9M | 225.69M | 154.46M |
| Total Liabilities | 5.14M | 10.54M | 22.18M | 18.51M | 48.93M |
| Total Equity | 9.42M | 87.65M | 218.72M | 207.18M | 105.53M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -79.66M | -102M | -17.58M | -27.49M | -46.3M |
| Investing | -28.64M | -29.07M | -108k | -108k | -117k |
| Financing | -4.2M | 36.52M | -212k | 6.81M | 49.72M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -26.68M | -48.57M | -75.56M | -98.05M | -102M |
| Investing | -17k | -8.56M | -35.31M | -48.15M | -29.07M |
| Financing | 12.92M | 123.11M | 212.49M | 87.84M | 36.52M |
| Market Cap | 86.37M |
| Price to Earnings Ratio | -0.72 |
| Price to Sales Ratio | 10.8 |
| Price to Cash Ratio | 3.36 |
| Price to Book Ratio | 0.79 |
| Dividend Yield | - |
| Shares Outstanding | 5.59M |
| Average Volume (1 week) | 953.46k |
| Average Volume (1 Month) | 1.63M |
| 52 Week Change | -98.58% |
| 52 Week High | 1,193.28 |
| 52 Week Low | 6.76 |
| Spread (Intraday) | 0.17 (1.1%) |
| Company Name | Tonix Pharmaceuticals Holding Corporation |
| Address |
769 basque way carson city, nevada 89706 |
| Website | https://www.tonixpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
